Search

Your search keyword '"Lin, Shu-Hai"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Lin, Shu-Hai" Remove constraint Author: "Lin, Shu-Hai"
128 results on '"Lin, Shu-Hai"'

Search Results

5. SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors

13. Supplementary Data from Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides

17. PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism

21. The glycolysis/HIF-1α axis defines the inflammatory role of IL-4-primed 2 macrophages

25. Type 2 Immune Response Plays A Critical Role in Trained Immunity

26. Themis is indispensable for IL-2 and IL-15 signaling in T cells

27. Mitochondrial C1qbp promotes differentiation of effector CD8 + T cells via metabolic-epigenetic reprogramming

29. Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells

30. Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function

31. Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells.

32. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells

33. Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake via Xc− for Glutathione Synthesis in Lung Cancer

34. Kynurenine analog 3-HAA is a ligand for transcription factor YY1

35. MDH1-mediated malate-aspartate NADH shuttle maintains the activity levels of fetal liver hematopoietic stem cells

36. Plasma metabolomic and lipidomic alterations associated with COVID-19

38. Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides

39. Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors

45. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells

46. Serum Metabolomics Reveals Personalized Metabolic Patterns for Macular Neovascular Disease Patient Stratification

47. Abstract 1058: Targeting pentose phosphate pathway (PPP) represents a novel therapeutic strategy for hepatocellular carcinoma (HCC) treatment

48. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia

Catalog

Books, media, physical & digital resources